128 related articles for article (PubMed ID: 8042860)
1. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses.
Lillie JW; Smee DF; Huffman JH; Hansen LJ; Sidwell RW; Kaddurah-Daouk R
Antiviral Res; 1994 Apr; 23(3-4):203-18. PubMed ID: 8042860
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir and other chemotherapy for herpes group viral infections.
Balfour HH
Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapies for herpes viral infections (types 1 - 8).
Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
5. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
6. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
[TBL] [Abstract][Full Text] [Related]
7. Does supplemental creatine prevent herpes recurrences?
Ness SR; McCarty MF
Med Hypotheses; 2001 Sep; 57(3):310-2. PubMed ID: 11516222
[TBL] [Abstract][Full Text] [Related]
8. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir for intravenous use. Committee on Infectious Diseases and Immunization, Canadian Paediatric Society.
Can Med Assoc J; 1984 Nov; 131(9):1045-6. PubMed ID: 6093977
[No Abstract] [Full Text] [Related]
10. Selective virus inhibitors.
De Clercq E
Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
[TBL] [Abstract][Full Text] [Related]
12. Drugs five years later: acyclovir.
Dorsky DI; Crumpacker CS
Ann Intern Med; 1987 Dec; 107(6):859-74. PubMed ID: 3318610
[TBL] [Abstract][Full Text] [Related]
13. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis.
Ganguly S; Elbayoumi T
Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.
Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R
J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
[TBL] [Abstract][Full Text] [Related]
17. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
18. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
Machida H; Ikeda T; Ashida N
Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
[TBL] [Abstract][Full Text] [Related]
20. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
